96 related articles for article (PubMed ID: 32703488)
1. RSK4: a new prognostic factor in glioma.
Chen L; Xu T; Jia Q; Wang X; Li M; Liang G
Pathol Res Pract; 2020 Aug; 216(8):153020. PubMed ID: 32703488
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma.
Fan L; Li P; Yin Z; Fu G; Liao DJ; Liu Y; Zhu J; Zhang Y; Wang L; Yan Q; Guo Y; Shao C; Huang G; Wang Z
Br J Cancer; 2013 Sep; 109(5):1137-46. PubMed ID: 23942078
[TBL] [Abstract][Full Text] [Related]
3. Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer.
Cai J; Ma H; Huang F; Zhu D; Zhao L; Yang Y; Bi J; Zhang T
Int J Clin Exp Pathol; 2014; 7(8):4959-70. PubMed ID: 25197367
[TBL] [Abstract][Full Text] [Related]
4. High RSK4 expression constitutes a predictor of poor prognosis for patients with clear cell renal carcinoma.
Ma J; Wang K; Chai J; Xu T; Wei J; Liu Y; Wang Y; Xu J; Li M; Fan L
Pathol Res Pract; 2021 Nov; 227():153642. PubMed ID: 34649054
[TBL] [Abstract][Full Text] [Related]
5. High expression of mitogen-activated and stress-activated protein kinase 1 indicates poor prognosis in patients with glioma.
Li H; Zhao C; Xu M; Yin M
Neuroreport; 2018 Oct; 29(15):1249-1255. PubMed ID: 30020192
[TBL] [Abstract][Full Text] [Related]
6. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
7. Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC.
Ma J; Li M; Chai J; Wang K; Li P; Liu Y; Zhao D; Xu J; Yu K; Yan Q; Guo S; Wang Z; Fan L
Diagn Pathol; 2020 Mar; 15(1):28. PubMed ID: 32209138
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
[TBL] [Abstract][Full Text] [Related]
9. Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer.
Xu J; Jia Q; Zhang Y; Yuan Y; Xu T; Yu K; Chai J; Wang K; Chen L; Xiao T; Li M
Pathol Res Pract; 2021 Mar; 219():153374. PubMed ID: 33621918
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
Mei Y; Liao X; Zhu L; Yang H
J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
[TBL] [Abstract][Full Text] [Related]
11. FGF2 as a potential prognostic biomarker for proneural glioma patients.
Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
[TBL] [Abstract][Full Text] [Related]
12. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
13. Effect of RSK4 on biological characteristics of colorectal cancer.
Ye Q; Wang X; Jin M; Wang M; Hu Y; Yu S; Yang Y; Yang J; Cai J
World J Surg Oncol; 2018 Dec; 16(1):240. PubMed ID: 30579335
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of RSK4 Transcript Isoforms in Cancer and Its Clinical Relevance.
Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
[TBL] [Abstract][Full Text] [Related]
15. RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.
Huo H; Ye X; Yang H; Li Q; Jiang Y
Oncol Rep; 2019 Dec; 42(6):2777-2787. PubMed ID: 31545499
[TBL] [Abstract][Full Text] [Related]
16. Decreased CDKL2 expression is correlated with the progression and poor prognosis of glioma.
Yi R; Yang S; Liao Y; Hu Z; Long H; Zeng Y; Wang X; Qiu C; Xu A; Lin J; Wu Z
Pathol Res Pract; 2020 May; 216(5):152920. PubMed ID: 32173142
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines.
Arechavaleta-Velasco F; Zeferino-Toquero M; Estrada-Moscoso I; Imani-Razavi FS; Olivares A; Perez-Juarez CE; Diaz-Cueto L
Med Oncol; 2016 Feb; 33(2):11. PubMed ID: 26732474
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types.
Dümmler BA; Hauge C; Silber J; Yntema HG; Kruse LS; Kofoed B; Hemmings BA; Alessi DR; Frödin M
J Biol Chem; 2005 Apr; 280(14):13304-14. PubMed ID: 15632195
[TBL] [Abstract][Full Text] [Related]
19. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]